Meeting Overview - The third extraordinary general meeting of shareholders was held on October 27, 2025, at the company's headquarters in Shanghai [2] - The meeting was convened by the board of directors, with the chairman participating remotely due to other commitments [3] - All current directors and supervisors attended the meeting, along with the board secretary and several senior executives [4] Voting and Resolutions - The meeting adopted a combination of on-site and online voting methods [3] - All proposed resolutions were passed without any objections [5][6][7] - The resolutions included the approval of the 2025 Restricted Stock Incentive Plan and the 2025 Stock Appreciation Rights Incentive Plan [5][6] Legal Compliance - The meeting's procedures and voting methods complied with the Company Law and the company's articles of association [3][8] - A law firm witnessed the meeting, confirming that all procedures were in accordance with relevant laws and regulations [8] Insider Trading Self-Examination - The company conducted a self-examination regarding insider trading related to the 2025 incentive plans, covering the period from April 11, 2025, to October 10, 2025 [9][10] - Four incentive plan participants were found to have traded company stock, but their actions were based on independent market assessments prior to the disclosure of insider information [11] - A brokerage firm involved in the trading also adhered to information barrier protocols, ensuring no insider information was utilized [12] Conclusion of Self-Examination - The company confirmed that no insider trading occurred during the examination period, and all actions by the involved parties complied with regulatory requirements [13]

Core Viewpoint - The report outlines the self-examination of insider trading activities related to the major asset restructuring of Zhongyan Inner Mongolia Chemical Co., Ltd. (hereinafter referred to as "Zhongyan Chemical") and its subsidiary Zhongyan (Inner Mongolia) Alkali Industry Co., Ltd. (hereinafter referred to as "Zhongyan Alkali"). The restructuring involves a targeted capital reduction by Zhongyan Alkali, which will subsequently become a wholly-owned subsidiary of Zhongyan Chemical [1][2]. Group 1 - The self-examination period for insider trading activities is defined as the six months prior to the first disclosure of the restructuring transaction (from December 20, 2024, to July 23, 2025) [3][4]. - The scope of the insider trading examination includes directors, senior management, controlling shareholders, and other related parties of both the listed company and the target company [3][4]. - The report indicates that the insider trading activities during the self-examination period do not constitute a violation of the Securities Law of the People's Republic of China, as the involved parties have provided accurate and complete self-reports [11][12]. Group 2 - Specific trading activities by insiders during the self-examination period are detailed, including purchases and sales of shares by various individuals, such as the chairman and vice president of Zhongyan Chemical [5][6]. - The chairman, Zhou Jie, reported buying 20,000 shares on January 2, 2025, and 3,900 shares on January 7, 2025, while other executives also engaged in similar trading activities [5][6]. - The report emphasizes that all involved parties have committed to not using insider information for trading and have provided assurances regarding the legality of their trading actions [6][10].